|
1
|
Gray RE and Harris GT: Renal cell
carcinoma: Diagnosis and management. Am Fam Physician. 99:179–184.
2019.PubMed/NCBI
|
|
2
|
Linehan WM and Ricketts CJ: The cancer
genome atlas of renal cell carcinoma: Findings and clinical
implications. Nat Rev Urol. 16:539–552. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Makhov P, Joshi S, Ghatalia P, Kutikov A,
Uzzo RG and Kolenko VM: Resistance to systemic therapies in clear
cell renal cell carcinoma: Mechanisms and management strategies.
Mol Cancer Ther. 17:1355–1364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lucarelli G, Loizzo D, Franzin R,
Battaglia S, Ferro M, Cantiello F, Castellano G, Bettocchi C,
Ditonno P and Battaglia M: Metabolomic insights into
pathophysiological mechanisms and biomarker discovery in clear cell
renal cell carcinoma. Expert Rev Mol Diagn. 19:397–407. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tegos T, Tegos K, Dimitriadou A and
Dimitriadis G: Current and emerging first-line systemic therapies
in metastatic clear-cell renal cell carcinoma. J BUON.
24:1340–1353. 2019.PubMed/NCBI
|
|
6
|
Schodel J, Grampp S, Maher ER, Moch H,
Ratcliffe PJ, Russo P and Mole DR: Hypoxia, hypoxia-inducible
transcription factors, and renal cancer. Eur Urol. 69:646–657.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Wang X, Xu L, Zhang J and Cao H:
Integrated analysis of the E2F transcription factors across cancer
types. Oncol Rep. 43:1133–1146. 2020.PubMed/NCBI
|
|
8
|
Pennycook BR, Vesela E, Peripolli S, Singh
T, Barr AR, Bertoli C and de Bruin RAM: E2F-dependent transcription
determines replication capacity and S phase length. Nat Commun.
11:35032020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kovesdi I, Reichel R and Nevins JR: Role
of an adenovirus E2 promoter binding factor in E1A-mediated
coordinate gene control. Proc Natl Acad Sci USA. 84:2180–2184.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ertosun MG, Hapil FZ and Nidai OO: E2F1
transcription factor and its impact on growth factor and cytokine
signaling. Cytokine Growth Factor Rev. 31:17–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kent LN and Leone G: The broken cycle: E2F
dysfunction in cancer. Nat Rev Cancer. 19:326–338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng L, Dou X, Song H, Gao R and Tang X:
TRPV1 acts as a tumor suppressor and is associated with immune cell
infiltration in clear cell renal cell carcinoma: Evidence from
integrated analysis. J Cancer. 11:5678–5688. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang W, Zhang M, Wang Q, Gu D, Huang Z,
Wang H, Xiang Y, Xia Q, Cui Z and Jin X: The SLC family are
candidate diagnostic and prognostic biomarkers in clear cell renal
cell carcinoma. Biomed Res Int. 2020:19329482020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng Y, Fang YC and Li J: PD-L1
expression levels on tumor cells affect their immunosuppressive
activity. Oncol Lett. 18:5399–5407. 2019.PubMed/NCBI
|
|
15
|
Wang H, Yan C and Ye H: Overexpression of
MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer
related to immune response. Exp Ther Med. 20:1725–1733. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martinez-Saez O, Borau PG, Alonso-Gordoa
T, Molina-Cerrillo J and Grande E: Targeting HIF-2 alpha in clear
cell renal cell carcinoma: A promising therapeutic strategy. Crit
Rev Oncol Hematol. 111:117–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Attwooll C, Denchi EL and Helin K: The E2F
family: Specific functions and overlapping interests. EMBO J.
23:4709–4716. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun CC, Li SJ, Hu W, Zhang J, Zhou Q, Liu
C, Li LL, Songyang YY, Zhang F, Chen ZL, et al: Comprehensive
analysis of the expression and prognosis for E2Fs in human breast
cancer. Mol Ther. 27:1153–1165. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiao Y, Li Y, Fu Z, Hou L, Chen Q, Cai Y,
Jiang P, He M and Yang Z: OGDHL expression as a prognostic
biomarker for liver cancer patients. Dis Markers. 2019:90371312019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei WY, Yan LH, Wang XT, Li L, Cao WL,
Zhang XS, Zhan ZX, Yu H, Xie YB and Xiao Q: E2F-1 overexpression
inhibits human gastric cancer MGC-803 cell growth in vivo. World J
Gastroenterol. 21:491–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang Z, Lin M, Li C, Liu H and Gong C: A
comprehensive review of the roles of E2F1 in colon cancer. Am J
Cancer Res. 10:757–768. 2020.PubMed/NCBI
|
|
22
|
Yin H, Lowery M and Glass J: In prostate
cancer C/EBPalpha promotes cell growth by the loss of interactions
with CDK2, CDK4, and E2F and by activation of AKT. Prostate.
69:1001–1016. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fang DZ, Wang YP, Liu J, Hui XB, Wang XD,
Chen X and Liu D: MicroRNA-129-3p suppresses tumor growth by
targeting E2F5 in glioblastoma. Eur Rev Med Pharmacol Sci.
22:1044–1050. 2018.PubMed/NCBI
|
|
24
|
Li SL, Sui Y, Sun J, Jiang TQ and Dong G:
Identification of tumor suppressive role of microRNA-132 and its
target gene in tumorigenesis of prostate cancer. Int J Mol Med.
41:2429–2433. 2018.PubMed/NCBI
|
|
25
|
Xu H, Fei D, Zong S and Fan Z:
MicroRNA-154 inhibits growth and invasion of breast cancer cells
through targeting E2F5. Am J Transl Res. 8:2620–2630.
2016.PubMed/NCBI
|
|
26
|
Lafta IJ: E2F6 is essential for cell
viability in breast cancer cells during replication stress. Turk J
Biol. 43:293–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moreno E, Toussaint MJM, van Essen SC,
Bongiovanni L, van Liere EA, Koster MH, Yuan R, van Deursen JM,
Westendorp B and de Bruin A: E2F7 is a potent inhibitor of liver
tumor growth in adult mice. Hepatology. 73:303–317. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kent LN, Rakijas JB, Pandit SK, Westendorp
B, Chen HZ, Huntington JT, Tang X, Bae S, Srivastava A, Senapati S,
et al: E2f8 mediates tumor suppression in postnatal liver
development. J Clin Invest. 126:2955–2969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo L, Jones MC, Liu Y, Yv S, Zhu Y and
Guo Y: Cross-cultural validation of the student nurse stress index
scale: A descriptive survey targeting student nurses in China. J
Affect Disord. 251:31–38. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Klutstein M, Nejman D, Greenfield R and
Cedar H: DNA methylation in cancer and aging. Cancer Res.
76:3446–3450. 2016. View Article : Google Scholar : PubMed/NCBI
|
